BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17765753)

  • 1. How does sublingual immunotherapy work?
    Frew AJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract]   [Full Text] [Related]  

  • 2. Sublingual immunotherapy: no more doubts.
    Passalacqua G; Lombardi C; Guerra L; Compalati E; Fumagalli F; Canonica GW
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):314-20. PubMed ID: 17066650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specific immunotherapy in desensitization of allergic patients. Oral administration instead of injections? (interview by Andrea Warpakowski)].
    Grevers G
    MMW Fortschr Med; 2003 May; 145(18):18. PubMed ID: 12808815
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse effects associated with sublingual immunotherapy.
    Passalacqua G; Valovirta E
    Clin Allergy Immunol; 2008; 21():469-75. PubMed ID: 18828524
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-dependence of sublingual immunotherapy shown by meta-analysis.
    Frati F; Incorvaia C; Scurati S; Sensi L; Marcucci F
    J Allergy Clin Immunol; 2011 Apr; 127(4):1076-7; author reply 1077-8. PubMed ID: 21306764
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen.
    Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on sublingual immunotherapy treatment regimes.
    Spangfort MD
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):244. PubMed ID: 17124783
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
    Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
    Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose sublingual immunotherapy: too much of the good?
    Reider N
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):125. PubMed ID: 16937740
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific immunotherapy by different allergen applications: subcutaneous, sublingual, oral or rectal administration and lymph node injection.
    Kleine-Tebbe J
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():87-95; discussion 95. PubMed ID: 20799448
    [No Abstract]   [Full Text] [Related]  

  • 13. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms.
    Bousquet J
    Allergy; 2005 Jan; 60(1):1-3. PubMed ID: 15575923
    [No Abstract]   [Full Text] [Related]  

  • 15. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?
    Lombardi C; Incorvaia C; Braga M; Senna G; Canonica GW; Passalacqua G
    Allergy; 2009 Jun; 64(6):849-54. PubMed ID: 19392995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAIS - Posological schedules.
    Bruno M
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):33-4. PubMed ID: 17761105
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy.
    Bauer CS; Rank MA
    J Allergy Clin Immunol; 2014 Sep; 134(3):765-765.e2. PubMed ID: 25171871
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel approaches in treating food allergy using allergens.
    Rancé F
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():157-63; discussion 164-7, 251-7. PubMed ID: 19710521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual administration of allergen desensitization.
    Reiber ME
    Tenn Med; 2002 Nov; 95(11):465-7. PubMed ID: 12436862
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease-modifying effect and economic implications of sublingual immunotherapy.
    Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2011 Jan; 127(1):44-5. PubMed ID: 21094517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.